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Abstract
OBJECTIVE: To study the effect of puerarin on ma-
trix metalloproteinase-2 (MMP-2) gene and protein
expression in human fetal scleral fibroblasts (HFS-
Fs) exposed to extremely low frequency electro-
magnetic fields (ELF-EMF).
METHODS: Cultured HFSFs were exposed to 0.2
mT ELF-EMF for 24 h. The experimental groups
were divided into subgroups treated with 0, 0.1, 1
and 10 μM puerarin respectively. The expression of
MMP-2 mRNA and protein were detected with re-
al-time polymerase chain reaction and west-
ern-blot analysis respectively.
RESULTS: MMP-2 mRNA and protein expression in-
creased by 0.793 and 1.130 folds respectively under
the exposure of ELF-EMFs at 0.2 mT flux density for
24 h. Puerarin at the concentration of 0.1 μM re-
versed this effect by 8.53% in mRNA and by 17.97%
in protein expression (P<0.05). The effect was more
prominent at higher concentrations (1 and 10 μM,
P<0.01).
CONCLUSION: Exposure to ELF-EMFs increased the
expression of MMP-2 mRNA and protein in HFSF
cells. Puerarin reversed the action to some extent
in a specific concentration range. Our results im-
plied that the puerarin might protect scleral tissue
from increased expression induced by exposure to
ELF-EMFs.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
The non-ionizing, non-thermal, 0 to 300 Hz frequen-
cy electromagnetic fields are generally defined as ex-
tremely low frequency electromagnetic fields
(ELF-EMFs).1 Exposure to ELF-EMFs has become in-
creasingly ubiquitous in many developed countries due
to the increasing use of electricity and relevant technol-
ogies. Notably, the most widespread extremely low fre-
quencies are generated by transmission and distribu-
tion of electrical power, 50 Hz in China/Europe and
60 Hz in North America. Electronic devices, communi-
cation systems and electric transmission lines are the
sources of ELF-EMFs and affect people in occupation-
al and general environments. As a result, both scientific
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and public concerns regarding the biological impact
and potential adverse health effects of ELF-EMFs have
risen steadily over the past decades. It was reported
that exposure to the ELF-EMFs for 3 months pro-
duced significant decrease in rat's plasma catalase activi-
ties.2 Baldi et al 3 analyzed the association between resi-
dential and occupational exposure to ELF-EMFs and
brain tumors in adults and the finding suggested that
exposure to ELF-EMFs in occupational or residential
setting might play a role in the occurrence of menin-
gioma.
In the previous study we found that ELF-EMFs treat-
ment caused decreased cell proliferation, decreased col-
lagen typeⅠ (COL1A1) expression, increased matrix
metalloproteinase-2 (MMP-2) expression in cultured
human fetal scleral fibroblasts (HFSFs). We speculated
that exposure to ELF-EMFs might contribute to patho-
logical scleral remodeling, which underlies some ocular
conditions such as myopia.4
In an effort to find an effective treatment to prevent or
reverse the effect of ELF-EMFs on HFSFs, we tested
puerarin extracted from Gegen (Radix Puerariae Loba-
tae), a traditional Chinese herb. Puerarin was found to
participate in the matrix remodeling process in various
tissues,5,6 but whether puerarin plays a protective role
in MMP-2 expression in HFSFs caused by ELF-EMFs
is unknown. Our study investigated the effect of puera-
rin in the concentration range from 0.1 to 10 μM on
MMP-2 gene and protein expression in HFSFs treated
with ELF-EMFs.
METHODS
ELF-EMFs exposure
Helmholtz coils (16 cm length, 14 cm width, 8 cm
height and 168 turns copper wire each) were designed
to generate an effective magnetic field in the range of
0-2 mT, with a sinusoidal wave of 50 Hz. The magnet-
ic flux density at the center of coil was measured by an
electromagnetic field radiation tester (EMF-827, Lu-
tron Electronic Enterprise CO., Ltd., Taiwan), and
controlled by varying the current in the coil.4
In a previous study, after exposure to ELF-EMFs at the
intensity of 0, 0.1, 0.2, 0.5 and 1.0 mT for 24 h, the
expression of MMP-2 mRNA/GAPDH mRNA in
HFSFs were 0.0085±0.0006, 0.0171±0.0026, 0.0135±
0.0015, 0.0146±0.0025 and 0.0139±0.0029 respective-
ly. The MMP-2 mRNA expression levels significantly
deviated from the normal level with approximately 0.1
mT (P=0.0379) and 0.2 mT (P=0.0210). In this study,
EMF of 0.2 mT intensity, the upper safety limit of
public exposure to non-ionizing radiation in the guide-
lines of International Commission on Non-ionizing
Radiation Protection,7 was used to detect the effect of
ELF-EMFs on MMP-2 mRNA expression in HFSFs
in various time duration. After exposure to ELF-EMFs
at the intensity of 0.2 mT for 0, 6, 12, 24, 36 and 48 h,
the expression of MMP-2 mRNA/GAPDH mRNA in
HFSFs were 0.0086±0.0005, 0.0053±0.0026, 0.0121±
0.0053, 0.0139±0.0017, 0.0246±0.0034 and 0.0298±
0.0032 respectively. The MMP-2 mRNA expression
level for 24 h exposure (P=0.0476) began to show sig-
nificant deviation from the normal level. Therefore,
the intensity of 0.2 mT, and 24 h were used as the pa-
rameters for ELF-EMFs exposure in this experiment.
The coil was placed in the cell culture incubator and
connected to power outlet 1 h before the commence-
ment of exposure in order to generate a stable sinusoi-
dal 50 Hz electromagnetic field at the intensity of 0.2
mT. For the control, the coil was not connected. The
temperature inside coil and exposed samples were man-
ually monitored during the experiment, and the tem-
perature variation was ±0.2℃.
Cell culture and treatment
HFSFs were obtained from Beijing Institute of Oph-
thalmology (Beijing, China). The cells were cultured in
six-well plates (Corning Life Sciences-Axygen Inc,
Union City, CA, USA) at a density of 5×105 cells/well
in Dulbecco's Modified Eagle Media (DMEM) with
10% fetal bovine serum (FBS, Invitrogen Gibco, Carls-
bad, CA, USA) at 37℃ with 5% CO2. The medium
was renewed every other day. Puerarin, final concentra-
tions of 0, 0.1, 1 and 10 μΜ, was added at the desig-
nated time.
Quantitative real time polymerase chain reaction
(qpcr) analysis
Total RNA was extracted using Trizol reagent and the
purity and concentration were analyzed with ultravio-
let spectrophotometer. The primers used were MMP-2
forward: 5' GGA AAA GAT TGA TGC G 3'; MMP-2
reverse: 5' GGT GCT GGC TGA GTA G 3'; glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) for-
ward: 5' CTC CTC CAC CTT TGA CGC 3'; GAP-
DH reverse: 5' CCA CCA CCC TGT TGC TGT 3'.
All primers were synthesized by Shanghai Sangon Bio-
logical Engineering Technology and Services (Shang-
hai, China). Polymerase chain reactions were per-
formed using the Syber Green quantitative fluorescent
PCR kit on ABI 7500. The RQ values (2-△△Ct) were cal-
culated for each group and the relative expression val-
ues were calculated as the ratio of the expressed genes
to GAPDH.8
Western blot analysis
Cells were lysed in RIPA buffer and protein concentra-
tion was determined. Thirty microgram total protein
was separated on 10% SDS-PAGE and transferred to
PVDF membranes. Mouse anti-MMP-2 (1∶1000 dilu-
tion; Abcam, Cambridge, MA, USA) and mouse an-
ti-β-actin (1∶2000 dilution, Abmart, Shanghai, Chi-
na) were used, followed by HRP-conjugated secondary
antibodies. Specific protein bands were visualized using
ECL detection kit (Beyotime, Shanghai, China) and
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quantified with Bio-Rad Chemi DocTM XRS+.
Statistical analysis
Data were analyzed with SPSS 16.0 (SPSS, Inc., Chica-
go, IL, USA). Quantitative variables were expressed as
mean ± standard deviation (SD). The differences be-
tween the groups were tested with ANOVA. Statistical
significance was accepted at P<0.05.
RESULTS
qPCR Analysis of MMP-2 gene expression
The RQ values of MMP-2 mRNA expression in HFS-
Fs after exposure to ELF-EMFs for 24 h at 0.2 mT
flux density treated with 0, 0.1, 1 and 10 μM puerarin
were 1.793 ± 0.095, 1.640 ± 0.044, 1.128 ± 0.085 and
0.950±0.049, respectively. MMP-2 mRNA expression
increased by 79.3% compared to the control (P<0.01,
t-test). MMP-2 mRNA expression gradually decreased
in the presence of puerarin with increasing concentra-
tions (Figure 1).
RQ value of MMP-2 in 0 μM puerarin group in-
creased compared with the control group (P<0.05);
RQ values of MMP-2 decreased in puerarin groups
treated with 0.1, 1 and 10 μM compared with 0 μM
puerarin group (P<0.05).
Western blot analysis of MMP-2
The MMP-2/β-actin gray value ratio of MMP-2 pro-
tein expression in HFSFs after exposure to ELF-EMFs
for 24 h at 0.2 mT flux density treated with 0, 0.1, 1
and 10 μM puerarin were 0.690±0.016, 0.566±0.033,
0.321 ± 0.030, 0.264 ± 0.028, respectively. Consistent
with qPCR results, MMP-2 protein level increased
1.130 folds compared with the control group (0.324±
0.022) (P<0.01). There was dose-dependent decrease
in MMP-2 protein expression after puerarin treatment
(Figure 2 and 3).
Compared with the control group, MMP-2 protein ex-
pression increased in 0 μM puerarin group; MMP-2
protein expressions were reduced in the puerarin
groups treated with 1 or 10 μM compared with 0 μM
puerarin group. The gray ratio value of MMP-2/β-ac-
tin was increased in 0 μM puerarin group compared
with the control group (P<0.05); the gray ratio values
of MMP-2/β-actin decreased in puerarin groups treat-
ed with 0.1, 1 and 10 μM compared with 0 μM puera-
rin group (P<0.05.)
DISCUSSION
Literature have demonstrated a consistent correlation
between ELF-EMFs and certain forms of cancer, specif-
ically childhood leukemia and hormone dependent can-
cers such as breast and prostate cancers, and other con-
ditions. In 2010, the International Commission on
Non-ionizing Radiation Protection recommended that
0.2 mT be the public limit and that 1 mT be the occu-
pational limit for the exposure of ELF-EMFs.7
Several studies reported the effect of ELF-EMFs on the
conjunctiva, cornea and retina. These studies showed
that ELF-EMFs caused morphological alterations of
the conjunctiva and reductions in the number of gob-
let cells, influenced the healing of corneal epithelial
wound and decreased adenylate kinase activity in reti-
nal rod outer segment membrane.9-12 Other studies doc-
umented that ELF-EMFs had the potential to increase
DNA damage in HL-60 leukemia cells, Rat-1 fibro-
blasts and WI-38 diploid fibroblasts.13
Posterior scleral remodeling of eyeball is characterized
by physical loss of the scleral ECM, primarily due to
the reduced production and increased degradation of
COL1A1,14,15 a major component of the scleral matrix.
Matrix metalloproteinases (MMPs) are a family of
Ca2+-activated, Zn2+-dependent proteases, secreted by a
Figure 1 mRNA expression of MMP-2 in HFSFs treated by pu-
erarin in different concentrations under exposure of to
ELF-EMFs for 24 h
MMP-2: matrix metalloproteinase-2; HFSFs: human fetal
scleral fibroblasts; ELF-EMF: extremely low frequency elec-
tromagnetic fields.
(μM)
Figure 2Western blot analysis of MMP-2
MMP-2: matrix metalloproteinase-2.
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Figure 3 protein expression of MMP-2 in HFSFs treated by
puerarin with different concentrations under exposure of
ELF-EMFs for 24 h
MMP-2: matrix metalloproteinase-2; HFSFs: human fetal
scleral fibroblasts; ELF-EMF: extremely low frequency elec-
tromagnetic fields.
(μM)
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wide variety of cells including fibroblasts and inflam-
matory cells. MMPs can degrade one or several constit-
uents of ECM and promote the remodeling of ECM.16
Previous research demonstrated that scleral fibroblasts
expressed several MMP subtypes, including MMP-1,
MMP-2, MMP-3 and MMP-9 but MMP-2 played a
major role because it could directly degrade collagen
typeⅠ,Ⅳ andⅤ in sclera.14,17,18
The research on the monomer of the active ingredients
from commonly used Traditional Chinese Medicine
has become an important focus in the field of alterna-
tive and complementary medicine. Puerarin is an isofla-
vone compound extracted from the dried roots of le-
gumes kudzu. It has the role of lowering intraocular
pressure, and improving microcirculation and antioxi-
dation. The injection of purified puerarin has been
widely used for the treatment of high blood pressure,
coronary heart disease and glaucoma.19,20 Puerarin has
been found to affect cell proliferation activity, regulate
matrix metabolism, and change the synthesis and secre-
tion of cytokines and enzymes. Wang et al 21 confirmed
that 0.001 μM puerarin could decrease MMP-9 expres-
sion in endometriosis tissue. Gong et al 5 found that
10-100 μM puerarin could raise the expression of col-
lagen protein type I in a dose-dependent manner in
some epiphyseal region of fetal rats. Hao et al 22 found
that puerarin was able to down-regulate peroxynitrite
level, and inhibit nitric oxide compounds to reduce ret-
inal pigment epithelial cell apoptosis in diabetic pa-
tients. Puerarin also has some hormone-like activities
and has protective effect against oxidative stress re-
sponse and osteoporosis.6
In previous reports, we showed that ELF-EMFs de-
creased the proliferation activity of HFSFs, down-regu-
lated the expression of collagen type Ⅰ, and up-regu-
lated the expression of MMP-2 mRNA and protein ex-
pression.4 The present study confirmed our results that
MMP-2 mRNA and protein expression increased by
0.793 and 1.130 folds respectively under the exposure
of ELF-EMFs at 0.2 mT flux density for 24 h. Further-
more, we showed that puerarin effectively reversed the
stimulatory effect of ELF-EMFs on MMP-2 expression
in HFSFs. Puerarin at the concentration of 0.1 μM re-
duced this effect by 8.53% in mRNA and 17.97% in
protein expression (P<0.05). The effect was more
prominent at its higher concentrations (1 and 10 μM,
P<0.01). Since puerarin has already been used in medi-
cal practice, our results suggested a potential option for
the treatment of extracellular matrix degradation of
sclera associated with various ocular conditions.
In sum, our study showed that ELF-EMFs stimulated
MMP-2 gene and protein expression in HFSFs, and
that puerarin partially reversed the stimulatory effect.
In our preliminary experiments, increased expressions
of extracellular signal-regulated kinase 1/2 (ERK 1/2),
p38 mitogen-activated protein kinase (p38 MAPK)
phosphorylation were detected after HFSFs exposed to
ELF-EMFs. These signal pathways could up-regulate
the expression of MMP-2 in fibroblasts.23,24 Our find-
ings warrant further investigation in order to interpret
how ELF-EMFs and MMP-2 affect the signal transduc-
tion pathway, and to develop puerarin as a medical op-
tion for ocular diseases involving scleral remodeling.
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